Savara Reports First Quarter Financial Results and Provides Business Update

Author's Avatar
May 15, 2023

Savara+Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the first quarter ending March 31, 2023 and provided a business update.